At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
TPAP +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Crossover Study to Compare Effectiveness of a Device Providing Pressure Drops During Inspiration (TPAP) to Continuous Positive Airway Pressure (CPAP) in Obstructive Sleep Apnea (OSA)
In Brief
A clinical study evaluating TPAP and CPAP for Obstructive Sleep Apnea. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The present study, TheraEquivalence, is a Phase 2 crossover study designed to examine the efficacy and safety of TheraPAP (TPAP) vs. CPAP alone in the treatment of OSA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedFeb 2024
Enrollment StartMar 2024
Primary CompletionJul 2024
TodayJul 2026
First PostedFeb 2, 2024
Enrollment StartMar 7, 2024
Primary CompletionJul 8, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.4 years ago
Interventions
TPAPother
Algorithm for modification of CPAP therapy where pressure is reduced during the inspiratory phase though much of the expiratory phase, then is returned to full pressure near the end of the expiratory phase. Note that the same device that delivers CPAP can also deliver TPAP
CPAPdevice
Gold standard for treating sleep apnea.